Bafna Pharmaceuticals (BAFNAPH.NS) Earnings Analysis
Bafna Pharmaceuticals (BAFNAPH.NS) has no confirmed upcoming earnings date. Trailing P/E 51.81.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BAFNAPH.NS next report earnings?
No confirmed upcoming earnings date is currently scheduled for BAFNAPH.NS. This page updates as the calendar is published.
BAFNAPH.NS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-25 | 1.16 INR | n/a | n/a | n/a |
| 2026-02-04 | 0.78 INR | n/a | n/a | n/a |
| 2025-11-10 | 1.32 INR | n/a | n/a | n/a |
| 2025-05-27 | 0.553 INR | n/a | n/a | n/a |
| 2025-02-06 | 0.4 INR | n/a | n/a | n/a |
| 2024-11-11 | 1.11 INR | n/a | n/a | n/a |
BAFNAPH.NS valuation and analyst view
| Trailing P/E | 51.81 |
|---|---|
| Trailing EPS | 4.684 INR |
| Price / book | 5.99 |
| Dividend yield | 0.00% |
| Market cap | 5.64B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Bafna Pharmaceuticals (BAFNAPH.NS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for BAFNAPH.NS. This page updates as the calendar is published.
Did BAFNAPH.NS beat earnings last quarter?
Consensus estimate data was not available for BAFNAPH.NS's 2026-05-25 report.
What is BAFNAPH.NS's current P/E ratio and EPS?
BAFNAPH.NS trades at a trailing P/E of 51.81 on trailing EPS of 4.6836575382927546 INR.
What do analysts rate BAFNAPH.NS?
BAFNAPH.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.